• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

足底出汗作为胸交感神经切除术后代偿性出汗风险较低的指标。

Plantar Sweating as an Indicator of Lower Risk of Compensatory Sweating after Thoracic Sympathectomy.

作者信息

Kargi Ahmet Bulent

机构信息

Department of Thoracic Surgery, Medical Park Hospital, Antalya, Turkey.

出版信息

Thorac Cardiovasc Surg. 2017 Sep;65(6):479-483. doi: 10.1055/s-0036-1579680. Epub 2016 Apr 4.

DOI:10.1055/s-0036-1579680
PMID:27043786
Abstract

Hyperhidrosis is a dysfunction of the autonomic nervous system that results in regional excessive sweating, mostly in the hands, armpits, and feet. A permanent and effective treatment of hyperhidrosis can be achieved by interruption of the thoracic sympathetic chain with endoscopic thoracic sympathectomy (ETS). However, some side effects, particularly compensatory sweating (CS), are the limitations of this procedure. The mechanism of CS and the associated risk factors are still controversial. The aim of this retrospective study was to determine the relationship with various parameters associated with CS in patients undergoing ETS.  ETS was performed on a total of 95 patients for palmar hyperhidrosis, axillary hyperhidrosis and facial blushing by the same surgeon. The mean age of the patients was 26.41 (± 7) years, and 54 (56.8%) were males. Palmar hyperhidrosis was present in 54 (56.8%) patients, axillary hyperhidrosis in 33 (34.7%) patients, and facial blushing in 8 (8.5%) patients. Moreover, 38 (40%) patients also had plantar sweating. The severity of CS was rated into three scales as less, moderate, and severe.  Regarding the severity of CS, 55 (57.9%) patients had no or less CS, 28 (29.5%) had moderate CS, and 12 (12.6%) patients had severe CS. Higher age group had a significant increased risk of severe CS ( = 0.03) ( = 0.262). Patients with body mass index (BMI) > 25 kg/m had a statistically significantly increased risk of severe CS ( = 0.016). Facial blushing resulted in severe CS in a significantly higher proportion of patients than by palmar and axillary hyperhidrosis ( = 0.001). The level of surgery was another important risk factor for CS, with the T2 level showing an increased risk of severe CS compared with T3 level ( < 0.001). Furthermore, plantar sweating was inversely and significantly related to the development of CS. Patients with plantar sweating had a significantly decreased incidence of developing CS ( = 0.015).  CS after thoracic sympathectomy for primary hyperhidrosis is the most displeasing and restrictive side effect. This study demonstrates that older age, operation level, facial blushing, and high BMI are risk factors for CS, as have been shown in several similar studies. An interesting finding of the present study is that there was a decreased incidence of CS among patients with plantar sweating. This situation may help us to distinguish high risk for CS before ETS operation.

摘要

多汗症是一种自主神经系统功能障碍,会导致局部多汗,主要出现在手部、腋窝和足部。通过内镜胸交感神经切除术(ETS)切断胸交感神经链可实现对多汗症的永久性有效治疗。然而,一些副作用,尤其是代偿性出汗(CS),是该手术的局限性。CS的机制及相关危险因素仍存在争议。这项回顾性研究的目的是确定接受ETS治疗的患者中与CS相关的各种参数之间的关系。

共有95例患者因手掌多汗症、腋窝多汗症和面部潮红接受了同一位外科医生的ETS治疗。患者的平均年龄为26.41(±7)岁,其中54例(56.8%)为男性。54例(56.8%)患者有手掌多汗症,33例(34.7%)患者有腋窝多汗症,8例(8.5%)患者有面部潮红。此外,38例(40%)患者也有足底出汗。CS的严重程度分为轻度、中度和重度三个等级。

关于CS的严重程度,55例(57.9%)患者无或有轻度CS,28例(29.5%)有中度CS,12例(12.6%)患者有重度CS。年龄较大的组发生重度CS的风险显著增加(P = 0.03)(OR = 0.262)。体重指数(BMI)>25 kg/m²的患者发生重度CS的风险在统计学上显著增加(P = 0.016)。面部潮红导致重度CS的患者比例显著高于手掌和腋窝多汗症患者(P = 0.001)。手术水平是CS的另一个重要危险因素,与T3水平相比,T2水平发生重度CS的风险增加(P < 0.001)。此外,足底出汗与CS的发生呈负相关且具有显著相关性。有足底出汗的患者发生CS的发生率显著降低(P = 0.015)。

原发性多汗症胸交感神经切除术后的CS是最令人不快和受限的副作用。本研究表明,年龄较大、手术水平、面部潮红和高BMI是CS的危险因素,这在几项类似研究中也已得到证实。本研究的一个有趣发现是,有足底出汗的患者中CS的发生率降低。这种情况可能有助于我们在ETS手术前区分CS的高风险患者。

相似文献

1
Plantar Sweating as an Indicator of Lower Risk of Compensatory Sweating after Thoracic Sympathectomy.足底出汗作为胸交感神经切除术后代偿性出汗风险较低的指标。
Thorac Cardiovasc Surg. 2017 Sep;65(6):479-483. doi: 10.1055/s-0036-1579680. Epub 2016 Apr 4.
2
Influence of Body Mass Index on Compensatory Sweating in Patients after Thoracic Sympathectomy due to Palmar Hyperhidrosis.体重指数对因掌部多汗症行胸交感神经切除术后患者代偿性出汗的影响。
Thorac Cardiovasc Surg. 2017 Sep;65(6):497-502. doi: 10.1055/s-0037-1599797. Epub 2017 Mar 10.
3
Predictors of outcome following endoscopic thoracic sympathectomy.内镜下胸交感神经切断术后预后的预测因素。
ANZ J Surg. 2014 Jan-Feb;84(1-2):68-72. doi: 10.1111/ans.12098. Epub 2013 Feb 21.
4
Long-Term Efficacy of T3 Versus T3+T4 Thoracoscopic Sympathectomy for Concurrent Palmar and Plantar Hyperhidrosis.T3 与 T3+T4 胸腔镜交感神经切断术治疗手掌和足底多汗症的长期疗效比较。
J Surg Res. 2021 Jul;263:224-229. doi: 10.1016/j.jss.2020.11.064. Epub 2021 Mar 7.
5
R3 versus R4 Thoracoscopic Sympathectomy for Severe Palmar Hyperhidrosis.R3与R4胸腔镜交感神经切除术治疗重度手掌多汗症
Thorac Cardiovasc Surg. 2017 Sep;65(6):491-496. doi: 10.1055/s-0037-1600113. Epub 2017 Mar 10.
6
Efficacy of Miniuniportal Video-Assisted Thoracoscopic Selective Sympathectomy (Ramicotomy) for the Treatment of Severe Palmar and Axillar Hyperhidrosis.迷你单孔电视辅助胸腔镜选择性交感神经切断术(分支切断术)治疗重度手掌及腋窝多汗症的疗效
Thorac Cardiovasc Surg. 2019 Aug;67(5):415-419. doi: 10.1055/s-0038-1642030. Epub 2018 May 8.
7
Endoscopic thoracic sympathectomy: long-term results for treatment of upper limb hyperhidrosis and facial blushing.内镜下胸交感神经切除术:治疗上肢多汗症和面部潮红的长期结果
Acta Chir Belg. 2011 Sep-Oct;111(5):293-7.
8
Comparison of only T3 and T3-T4 sympathectomy for axillary hyperhidrosis regarding treatment effect and compensatory sweating.仅T3交感神经切除术与T3-T4交感神经切除术治疗腋窝多汗症的疗效及代偿性出汗比较。
Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):263-7. doi: 10.1093/icvts/ivt160. Epub 2013 May 3.
9
Sympathectomy for hyperhidrosis: should we place the clamps at T2-T3 or T3-T4?治疗多汗症的交感神经切除术:我们应该在T2 - T3还是T3 - T4处放置夹子?
Clin Auton Res. 2006 Dec;16(6):384-9. doi: 10.1007/s10286-006-0374-z. Epub 2006 Nov 2.
10
One-year follow-up period after transumbilical thoracic sympathectomy for hyperhidrosis: outcomes and consequences.经脐胸交感神经切断术治疗多汗症一年随访期:结果和后果。
J Thorac Cardiovasc Surg. 2014 Jan;147(1):25-8. doi: 10.1016/j.jtcvs.2013.08.062. Epub 2013 Oct 28.

引用本文的文献

1
Which patients are more likely to experience compensatory hyperhidrosis after endoscopic thoracic sympathectomy: a meta-analysis and systematic review.哪些患者在内镜下胸交感神经切除术后更易出现代偿性多汗症:一项荟萃分析与系统评价
PeerJ. 2025 Mar 18;13:e19097. doi: 10.7717/peerj.19097. eCollection 2025.
2
Comparison of the effectiveness and safety between ramicotomy and sympathetic chain interruption in the treatment of primary hyperhidrosis: a meta-analysis.肉毒素注射与交感神经链切断术治疗原发性多汗症的有效性和安全性比较:一项荟萃分析。
Clin Auton Res. 2025 Feb 5. doi: 10.1007/s10286-025-01115-x.
3
Predictors of Compensatory Sweating and Satisfaction Following Endoscopic Thoracic Sympathetic Chain Clipping for Palmar/Axillary Hyperhidrosis.
内镜下胸交感神经链切断术治疗手掌/腋窝多汗症后代偿性出汗及满意度的预测因素
J Clin Med. 2025 Jan 8;14(2):326. doi: 10.3390/jcm14020326.
4
Patients' satisfaction after bilateral thoracoscopic sympathicolysis.双侧胸腔镜交感神经切断术后患者的满意度
J Minim Access Surg. 2023 Oct-Dec;19(4):478-481. doi: 10.4103/jmas.jmas_179_22.
5
Effects of lower thoracic sympathicotomy on plantar hyperhidrosis.下胸交感神经切断术对足底多汗症的影响。
J Thorac Dis. 2021 Feb;13(2):664-670. doi: 10.21037/jtd-20-2437.
6
Heart rate variability as a potential diagnostic tool to predict compensatory hyperhidrosis after sympathectomy in patients with primary focal hyperhidrosis.心率变异性作为预测原发性局灶性多汗症患者交感神经切除术后代偿性多汗症的潜在诊断工具。
J Thorac Dis. 2020 Nov;12(11):6789-6796. doi: 10.21037/jtd-20-2038.
7
Can we predict the compensatory hyperhidrosis following a thoracic sympathectomy?我们能否预测胸交感神经切除术后的代偿性多汗症?
Indian J Thorac Cardiovasc Surg. 2019 Apr;35(2):190-195. doi: 10.1007/s12055-018-0769-1. Epub 2018 Dec 14.